Physician profile
Chad B Stephens
NPI 1659372290
$1,039,516.81
in general payments reported to CMS, 2019-2025
21 companies · $86K in 2025
The $86K reported for 2025 was more than what 99% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164K · 2020: $173K · 2021: $183K · 2022: $177K · 2023: $134K · 2024: $123K · 2025: $86K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $90K · Consulting Fee: $89K · Honoraria: $84K · Travel and Lodging: $70K · Food and Beverage: $9,948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $89,676.53 |
| Consulting Fee | $88,820.00 |
| Honoraria | $84,291.00 |
| Travel and Lodging | $69,873.68 |
| Food and Beverage | $9,947.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $425,446.28 | 2020-2025 | Ha Minuteman G3-R, Liberty Si, Patriot Si |
| Avanos Medical | $424,009.06 | 2019-2025 | Coolief* Cooled Radiofrequency, Coolief, Cooled Rfa |
| Stimwave Technologies Incorporated | $64,867.45 | 2019-2021 | |
| Boston Scientific Corporation | $40,801.59 | 2019-2025 | General - Pain Management |
| Vertiflex, INC. | $37,703.38 | 2019 | |
| Ferring Pharmaceuticals INC. | $25,133.21 | 2023-2025 | Euflexxa |
| Foundation Fusion Solutions, LLC | $9,038.44 | 2020-2022 | |
| Genesys Orthopedics Systems, L.L.C. | $5,595.44 | 2022 | |
| Mml US, INC. | $2,265.33 | 2022-2024 | Reactiv8 |
| Abbott Laboratories | $1,402.97 | 2020-2025 | Proclaim, Octrode, Eterna |
| Medtronic, INC. | $1,071.29 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Spr Therapeutics, INC | $875.83 | 2022 | |
| Relievant Medsystems, INC. | $351.48 | 2019-2021 | |
| Hydrocision, INC. | $284.47 | 2019-2023 | Tenjet |
| Curonix LLC | $205.73 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $193.80 | 2020-2021 | |
| Nevro Corp. | $97.06 | 2020 | |
| Medtronic USA, INC. | $70.46 | 2020 | |
| Nalu Medical, INC. | $44.46 | 2022-2024 | Nalu Neurostimulation System |
| Intrinsic Therapeutics | $41.51 | 2021 | |
| Orthofix Medical, INC. | $17.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$193,573.86 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.